Envisioning the Future of Biotech with Alector

Alector is publicly-traded biotech company developing therapies to cure neurodegenerative diseases like Alzheimer's and Frontotemporal Dementia.

Looking to solidify its position as a leader in biomedical research, Alector asked Barrel to design and develop a new website that could match its bold mission. We needed to create an easy-to-navigate experience that could seamlessly showcase Alector's expanse of complicated research and cutting-edge therapeutics.

In order to capture Alector's unique vision, we worked closely with their team to evolve the company’s branding into something sophisticated and intimate. As part of this process, our team created several pieces of original content to elevate the overall brand look. Our use of double exposures (above and below) nods to Alector’s approach of “looking inward to find a cure."

With a growing portfolio of clinical trials and new discoveries on the horizon, Alector also needed a tool to showcase its progress to potential investors. With this in mind, our team developed a series of dynamic diagrams and illustrations, all updatable via Wordpress CMS.

Check out the website at alector.com

Interested in collaborating on a project?

Get Started

Latest Updates

Insights from K:BOS 2026 for CPG Brands: AI, Agents, and the End of the Siloed Customer Journey

Insights

Make Your Mobile Site Holiday-Ready

Insights

Campaign Ideas That Cut Through BFCM Inbox Noise

Insights

Stop Batch-and-Blast: A Segmentation Framework for Holiday Email

Insights

Make Bundling Your BFCM Advantage

Insights

How We Helped Cabot Creamery Build AI Authority in a Competitive Category

News

Personalization at Scale: Email, SMS, Push, and Onsite

Insights

Gift Guides for BFCM: Guiding Shoppers Through the Holiday Rush

Insights